Singapore has built up a strong research and development (R&D) base, thanks to sustained investment over many years. A total of $25 billion will be committed to research, innovation and enterprise (RIE) under the Government's latest five-year plan, or RIE2025, from this year to 2025.
The benefits derived from R&D have also been substantial, such as in the national effort to combat Covid-19. The scaling up of Covid-19 testing capability here owes much to locally developed test kits. Diagnostic innovations from Singapore laboratories were quickly translated into clinically validated, mass-manufactured test kits through close collaboration between research institutions, healthcare providers and local medical technology manufacturers.